Abstract
Background
Mismanaged prescribing and use of medication among elderly puts major pressure on current healthcare systems. Performing a medication review, a structured critical examination of a patient's medications, during hospital stay with active follow-up into primary care could optimise treatment benefit and minimise harm. However, a lack of high quality evidence inhibits widespread implementation. This manuscript describes the rationale and design of a pragmatic cluster-randomised, crossover trial to fulfil this need for evidence.
Aim
To study the effects of hospital-initiated comprehensive medication reviews, including active follow-up, on elderly patients' healthcare utilisation compared to 1) usual care and 2) solely hospital based reviews.
Design
Multicentre, three-treatment, replicated, cluster-randomised, crossover trial.
Setting
8 wards with a multidisciplinary team within 4 hospitals in 3 Swedish counties.
Participants
Patients aged 65 years or older, admitted to one of the study wards.
Exclusion criteria
Palliative stage; residing in other than the hospital's county; medication review within the last 30 days; one-day admission.
Interventions
1, comprehensive medication review during hospital stay; 2, same as 1 with the addition of active follow-up into primary care; 3, usual care.
Primary outcome measure
Incidence of unplanned hospital visits during a 12-month follow-up period.
Data collection and analyses
Extraction and collection from the counties' medical record system into a GCP compliant electronic data capture system. Intention-to-treat-analyses using hierarchical models.
Relevance
This study has a high potential to show a reduction in elderly patients' morbidity, contributing to more sustainable healthcare in the long run.
Mismanaged prescribing and use of medication among elderly puts major pressure on current healthcare systems. Performing a medication review, a structured critical examination of a patient's medications, during hospital stay with active follow-up into primary care could optimise treatment benefit and minimise harm. However, a lack of high quality evidence inhibits widespread implementation. This manuscript describes the rationale and design of a pragmatic cluster-randomised, crossover trial to fulfil this need for evidence.
Aim
To study the effects of hospital-initiated comprehensive medication reviews, including active follow-up, on elderly patients' healthcare utilisation compared to 1) usual care and 2) solely hospital based reviews.
Design
Multicentre, three-treatment, replicated, cluster-randomised, crossover trial.
Setting
8 wards with a multidisciplinary team within 4 hospitals in 3 Swedish counties.
Participants
Patients aged 65 years or older, admitted to one of the study wards.
Exclusion criteria
Palliative stage; residing in other than the hospital's county; medication review within the last 30 days; one-day admission.
Interventions
1, comprehensive medication review during hospital stay; 2, same as 1 with the addition of active follow-up into primary care; 3, usual care.
Primary outcome measure
Incidence of unplanned hospital visits during a 12-month follow-up period.
Data collection and analyses
Extraction and collection from the counties' medical record system into a GCP compliant electronic data capture system. Intention-to-treat-analyses using hierarchical models.
Relevance
This study has a high potential to show a reduction in elderly patients' morbidity, contributing to more sustainable healthcare in the long run.
Original language | English |
---|---|
Pages (from-to) | 126-132 |
Journal | Contemporary Clinical Trials |
Volume | 61 |
DOIs | |
Publication status | Published - Oct 2017 |